Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Tag
  • C-6xHis
    (1)
  • N-6xHis
    (1)
  • N-His
    (1)
TargetMol | Tags By Expression System
  • E. coli
    (2)
  • HEK293 Cells
    (1)
TargetMol | Tags By Species
  • Human
    (3)
TargetMol | Tags By SPR-compatible Buffer
  • Buffer exchange required
    (3)
Filter
Search Result
Results for "

imp-4

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
TargetMolTargetMolCompare
TIMP-4 Protein, Human, Recombinant (His)
Tissue inhibitor of metalloproteinases 4, TIMP-4, TIMP4, Metalloproteinase inhibitor 4
TMPJ-01289
Expression system: HEK293 Cells
Length: 30-224, Full Length of Mature Protein
Activity: Not Tested
  • Inquiry Price
7-10 days
Size
QTY
TargetMolTargetMolCompare
IMPase2 Protein, Human, Recombinant (His)
Myo-Inositol Monophosphatase A2, Inositol-1(or 4)-Monophosphatase 2, Inositol Monophosphatase 2, IMPase 2, IMPA2, IMP.18P, IMP 2
TMPJ-00660
Inositol monophosphatase 2, also known as Inositol-1(or 4)-monophosphatase 2, Myo-inositol monophosphatase A2 and IMPA2, is an enzyme which belongs to the inositol monophosphatase family. IMPA2 catalyzes the dephosphoylration of inositol monophosphate with cofactor Magnesium and Inhibited by high Li+ and restricted Mg2+ concentrations. IMPA2 plays an important role in phosphatidylinositol signaling. IMPA2 can use the myo-inositol monophosphates, scylloinositol 1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates. IMPA2 is a pharmacological target for lithium Li(+) action in brain, it is considered to have a role in schizophrenia and bipolar disorder.
  • Inquiry Price
7-10 days
Size
QTY
TargetMolTargetMolCompare
IMPA1 Protein, Human, Recombinant (His)
inositol(myo)-1(or 4)-monophosphatase 1, IMPA, IMP
TMPY-02394
IMPA1 (Inositol Monophosphatase 1) is a Protein Coding gene. This gene encodes an enzyme that dephosphorylates Myo-inositol monophosphate to generate free Myo-inositol, a precursor of phosphatidylinositol, and is, therefore, an important modulator of intracellular signal transduction via the production of the second messenger's myoinositol 1,4,5-trisphosphate and diacylglycerol. Despite its many physiological functions, no clinical phenotype has been assigned to this gene dysfunction to date. Additionally, IMPA1 is the main target of lithium, a drug that is at the forefront of treatment for bipolar disorder. IMPA1 is widely expressed in the testis, thyroid, and other tissues. Diseases associated with IMPA1 include Mental Retardation, Autosomal Recessive 59, and Bipolar Disorder.
  • Inquiry Price
7-10 days
Size
QTY